Compounds that inhibit cholinesterase
US8101782B2 · kind B2 · utility
12Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2008 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Aug 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.